Dose escalation PET imaging for safety and effective therapy dose optimization of a bispecific antibody
Selecting the dose for efficacy and first-in-human studies of bispecific antibodies (BsAbs) is a challenging process. Herein, positron emission tomography (PET) imaging with 89Zr-labeled IBI322, an anti-CD47/PD-L1 BsAb, was used to optimize the safety and effective therapy dose. By labeling with 89Z...
Saved in:
Main Authors: | Yan Wang (Author), Donghui Pan (Author), Chenrong Huang (Author), Bingliang Chen (Author), Mingzhu Li (Author), Shuaixiang Zhou (Author), Lizhen Wang (Author), Min Wu (Author), Xinyu Wang (Author), Yicong Bian (Author), Junjie Yan (Author), Junjian Liu (Author), Min Yang (Author), Liyan Miao (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose escalation of a curcuminoid formulation
by: Crowell James, et al.
Published: (2006) -
A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults
by: Suping Niu, et al.
Published: (2022) -
High‐dose intranasal insulin in an adaptive dose‐escalation study in healthy human participants
by: Florian Schmitzberger, et al.
Published: (2024) -
The estimation and translation uncertainties in applying NOAEL to clinical dose escalation
by: Chao Chen, et al.
Published: (2024) -
Pharmacokinetics, pharmacodynamics, and safety of frunexian in healthy Chinese volunteer adults: A randomized dose‐escalation phase I study
by: Jia‐yu Zhang, et al.
Published: (2024)